Pharmaceutical Brand Protection & Anti-Counterfeiting


Zurich, Switzerland

Protecting The Pharmaceutical Industry Against Illicit Trade And Falsified Medicines

With sales of falsified, substandard and counterfeit pharmaceuticals estimated at around $200 billion annually, the illicit pharmaceutical market tops the luxury goods, alcohol and even tobacco industry's illicit sales as the most lucrative imitation market. Such a profitable market continues to attract specialist counterfeiters and organised crime, making it clear that challenge of illicit pharmaceuticals is only growing despite public and private efforts.

The FMD is here and companies trading in the European market have serialised - so what's next in the fight against fakes? Can you say that your supply chain is now secure and your regional market presence risk free? If so, you are now in a unique industry position. If not - don't worry, that is why we are bringing the industries leading supply chain, brand protection and anti-counterfeiting experts together in Zurich this June.

We know that there is no single way for brands to prevent the illegal copying of their products, and that global regulations, such as the FMD and DSCSA, are only one step in the right direction. With a focus on understanding the scope and weaknesses in your current brand protection strategy, and pinpointing the best opportunities for greater supply chain securitisation, this year's forum is designed to give you the tools and connections to move past FMD compliance and into proactive brand and supply chain protection.

Join Discussions With Industry Experts On:

  • Understanding how FMD implementation can add value to your brand protection efforts beyond serialisation
  • How to maximise your global protection efforts through public sector and private sector collaboration
  • Optimising your supply chain visibility by pinpointing and mitigating your weaknesses
  • Balancing your brand exposure and external partner selection in emerging markets to minimise the presence of counterfeit materials
  • Establishing a holistic risk profile to map out your global brand presence and supply chain pressure-points. Plus much more.

Benefits Of Attending The Pharmaceutical Brand Protection And Anti-Counterfeiting Forum

This is the only brand protection and anti-counterfeiting event  for the pharmaceutical industry. By attending the Pharmaceutical Brand Protection and Anti-Counterfeiting Conference, you will:
  1. Understand how FMD implementation can add value to your brand protection efforts beyond serialisation
  2. Learn how to maximise your global protection efforts through public sector and private sector collaboration
  3. Optimise your supply chain visibility by pinpointing and mitigating your weaknesses
  4. Balance your brand exposure and external partner selection in emerging markets to minimise the presence of counterfeit materials
  5. Gain insights on establishing a holistic risk profile to map out your global brand presence and supply chain pressure-points
  6. Understand how to spot counterfeits in your supply chain
  7. Develop a 360 degree anti-counterfeiting approach using overt and covert technology applications
  8. Increased networking opportunities as this year's event will be co-located with the Packaging and Labelling Summit 2019

Who Should Attend The Pharmaceutical Brand Protection And Anti-Counterfeiting Forum

Pharmaceutical professionals including:
  • Head of Supply Chain
  • Head of Brand Protection
  • Head of Anti-Counterfeiting
  • Head of Product Security
  • Head of Quality Assurance
  • Regulatory Affairs Manager
Solution and service providers offering:
  • Authentication solutions
  • Serialisation and traceability solutions
  • Block chain solutions
  • Brand protection solutions
  • Pharmaceutical supply chain consultancy

Speakers

  • Stanislas Barro, Global Head of Anti-Counterfeiting, Novartis
  • Alexander Habath, Security Lead EU, Associate Director, Global Security, Biogen
  • Mike Isles, Executive Director, ASOP EU
  • Joseph Buerger, Head of Brand Protection, Takeda
  • Antoine Tracq Tracq, Head of Global Business Processes Logistics and Serialisation, Galderma
  • Bernard Leroy, Director General, International Institute of Research Against Counterfeit Medicines, IRACM
  • Thomas Woods, Senior Consultant, Healthcare, World Bank
  • Mick Heywood, Supply Chain and Procurement Lead, GW Pharma
  • Jeffrey Hardy, Director General, TRACIT
  • Ifigenia Dimitriadou, Senior Manger Serialisation and Logistics, Celgene
  • Sven Bergmann, Managing Partner, Venture Global & Senior Advisor, Anti-Illicit Trade, Partnership for Safe Medicines
  • Professor Atholl Johnston, Science Director, Analytical Services International
  • Mark Willis, MDR and Compliance, Johnson & Johnson
  • Roland Weibel, Industry Engagement Manager Healthcare, GS1
  • Rodney Schaddee Van Dooren, Director, Illicit Trade Prevention, EMEA and PMI Duty Free, Philip Morris International
Conference Day One - 18th June 2019

Conference Day Two - 19th June 2019

Workshop Day - 20th June 2019

Venue

Crowne Plaza Zurich
Badenerstrasse 420
Zurich 8040
Switzerland
Website: http://www.ihg.com/crowneplaza/hotels/us/en/zurich/zrhha/hoteldetail#hotel-contact
Phone: + 41-44-4044444

Accommodation

Travel and accommodation are not included in the conference fee; however we have put together a HotelMap that displays discounted accommodation for hotels in the area near to Pharmaceutical Brand Protection & Anti-Counterfeiting 2019. The map displays live availability and allows you to book directly with each hotel: https://www.HotelMap.com/pro/MQHEQ

Please note: We will never recommend, approve or appoint any third party rooming service to act on our behalf. Please be extremely wary if you are approached by any such companies. We will always endeavour to negotiate the best available rates for you so please use the HotelMap link provided; this shows live availability and rates for all hotels in the area and allows you to book directly with the hotel of your choice within your budget.